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The nucleocapsid (N) protein of hantaviruses encapsidates both viral genomic and antigenomic RNAs,
although only the genomic viral RNA (vRNA) is packaged into virions. To define the domain within the
Hantaan virus (HTNV) N protein that mediates these interactions, 14 N- and C-terminal deletion constructs
were cloned into a bacterial expression vector, expressed, and purified to homogeneity. Each protein was
examined for its ability to bind the HTNV S segment vRNA with filter binding and gel electrophoretic mobility
shift assays. These studies mapped a minimal region within the HTNV N protein (amino acids 175 to 217) that
bound vRNA. Sequence alignments made from several hantavirus N protein sequences showed that the region
identified has a 58% identity and an 86% similarity among these amino acid sequences. Two peptides
corresponding to amino acids 175 to 196 (N1) and 197 to 218 (N2) were synthesized. The RNA binding of each
peptide was measured by filter binding and competition analysis. Three oligoribonucleotides were used to
measure binding affinity and assess specificity. The N2 peptide contained the major RNA binding determinants, while the N1 peptide, when mixed with N2, contributed to the specificity of vRNA recognition.
The N protein interacts with the three different vRNAs—
vRNA, cRNA, and mRNA—during replication; although the
molecular basis for the differential activities is not completely
understood. It is likely that specific sequences or structures
present in the vRNA molecules are involved. These structures
could provide a point of nucleation for subsequent encapsidation of the entire genomic (vRNA) or antigenomic (cRNA)
RNA segment, but not the mRNA. Two in vitro studies have
addressed the interaction of the N protein with RNA by measurement of the binding affinity of bacterially expressed and
purified N protein with vRNA and non-vRNA. In one study, a
specific interaction was not observed, although binding of
vRNA to filter-immobilized N protein was reported (9). In the
second study, the HTNV N protein demonstrated a preference
for its S segment vRNA as compared to its binding with an
RNA encoding the open reading frame (ORF) of the S segment (23). Furthermore, a strong preference was noted for the
S segment vRNA as compared to nonspecific RNA (23). Additional experiments found the 5⬘ end of the S segment vRNA
to be necessary and sufficient for the binding reaction (24).
Recently, preferential binding of the Bunyamwera virus
(BUNV) N protein to the 5⬘ end of the S segment vRNA has
also been reported (17). BUNV is also a member of the Bunyaviridae family, genus Bunyavirus, and has a replication strategy similar to that of the hantaviruses. Both the HTNV and
BUNV N proteins have similar dissociation constants (53 and
80 nM, respectively) for their S segment vRNA substrates in
the presence of magnesium ions (17, 23). These values are
comparable to the dissociation constant reported for the human immunodeficiency virus type 1 (HIV-1) nucleocapsid
(NC)-SL2 complex, 110 ⫾ 50 nM (3), which has been proposed
to be a major determinant in genome recognition.

Viruses within the Hantavirus genus, family Bunyaviridae,
can cause one of two serious illnesses in humans, hantavirus
pulmonary syndrome or hemorrhagic fever with renal syndrome (19). Sin Nombre virus and Hantaan virus (HTNV) are
the prototypic hantaviruses for each disease, respectively.
While researchers continue to identify additional hantaviruses
throughout the world (19), we know only a few details of the
molecular and biochemical functions of the viral proteins that
orchestrate the virus life cycle. Hantaviruses have a negativestrand, tripartite genome that encodes an RNA-dependent
RNA polymerase (L segment), the nucleocapsid (N) protein (S
segment), and the G1 and G2 glycoproteins (M segment) (20,
21). We have been interested in the defining the mechanism by
which N protein binds viral RNA (vRNA), because this function is essential to its role in encapsidation and ribonucleoprotein (RNP) complex formation and might have regulatory roles
in the viral life cycle. The N protein encapsidates genomic and
antigenomic vRNAs; however, only the genomic vRNA is
packaged into the mature virion (12). Each genomic vRNA
associates with the N protein, and probably the viral polymerase, to create three distinct RNPs (22). Apart from the role it
plays in the formation of the RNP, the hantavirus N protein
has been suggested to play a functional role in replication and
transcription. In particular, the N protein may modulate the
switch of virus RNA synthesis from transcription to replication,
as reported for analogous proteins in other negative-strand
viruses (4, 11, 18).
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A specific RNA binding domain (RBD), one that shows
preference for viral genomic RNAs, has not been defined for
any hantavirus N protein. For HTNV and Puumala virus, a
nonspecific RNA binding activity was reported to reside in the
carboxyl terminus of their respective N proteins (9). To map
the domain of the N protein that specifically interacts with viral
nucleic acids, we prepared several deletion constructs encoding
the HTNV N protein truncated at either the N terminus, the C
terminus, or both. The constructs were expressed in Escherichia coli, and the protein products were purified by Ni2⫹nitrilotriacetic acid (NTA) chromatography. The HTNV N
protein and its derivatives were assayed for their binding affinity for vRNA to map the site in the N protein that specifically interacted with vRNA.
MATERIALS AND METHODS
Oligonucleotides and enzymes. Oligonucleotide PCR primers were synthesized by Integrated DNA Technologies (Coralville, Iowa). Restriction enzymes
and Vent polymerase were purchased from New England Biolabs, Beverly, Mass.
T4 DNA ligase and kinase were purchased from Gibco-BRL (Grand Island,
N.Y.). All chemicals were purchased from Sigma (St. Louis, Mo.).
Construction of HTNV N protein truncations N⌬90, N⌬209, N⌬300, C⌬130,
and C⌬255. PCR was used to amplify and construct deletions of the HTNV N
protein ORF from pHTNV-N (23). Primers were designed to reamplify the
entire plasmid yet delete the region of interest in the HTNV S segment ORF.
Specific details are provided in the following paragraph. In general, PCR products were purified with QIAquick gel extraction kit (Qiagen, Chatsworth, Calif.).
The nucleotide sequences of all clones were confirmed by bidirectional sequencing with the LiCOR (Lincoln, Nebr.) model 4200 IR2 automated sequencer.
Each clone was constructed with a hexahistidine tag at the C terminus, which has
been previously shown to not interfere with the RNA binding properties of the
N protein (9, 23).
Deletions were created in the N terminus by using a universal reverse primer
(pET23b-R primer) and different forward primers that incorporated an NdeI site
(shown in italics below) to facilitate removal of sequences in the 5⬘ end of the S
segment ORF. The PCR products were recircularized with T4 DNA ligase,
transformed into E. coli DH-5␣ cells (Life Technologies), and screened with
NdeI. The pET23b-R primer (GACGTCATATGTATATCTCCTTCTTAAAGT
TAAAC-3⬘) was used as the reverse primer for cloning N⌬90, N⌬209, and
N⌬300 and contained sequence from 238 to 268 of the pET21b and pET23b
plasmids (underlined). The forward primers were as follows: N⌬90 primer (5⬘GACGTCATATGGAGAGGTCAATGCTCAGTTAT-3⬘), containing nucleotides 274 to 294 of the HTNV S segment ORF (underlined); N⌬209–5⬘ primer
(5⬘-GACGTCATATGGGGCTCTACCCTGCACAG-3⬘), containing nucleotides 610 to 628 of the HTNV S segment ORF (underlined); and the N⌬300
primer (5⬘-GACGTCATATGGAGTCACCATCATCAATATGG-3⬘), containing nucleotides 897 to 918 of the HTNV S segment ORF (underlined).
Deletions were created in the C terminus by using a universal forward primer
(pET23b-F primer) and different reverse primers which incorporated a XhoI site
(shown in italics in each primer below) to facilitate removal of sequences in the
3⬘ end of the S segment ORF. The PCR products were recircularized with T4
DNA ligase, transformed into E. coli DH-5␣ cells, and screened with XhoI. pET
23b-F primer, 5⬘-ATCCGCTCGAGCACCACCACCACCACCAC-3⬘, containing a hexahistidine tag from the pET21b or pET23b plasmid(underlined), was
used as a forward primer for cloning C⌬130 and C⌬255. The following primers
were synthesized with an XhoI site at their 5⬘ end (italics): C⌬130-3⬘ primer
(5⬘-ATCCGCTCGAGAATATCTTCAATCATGCTACAGCCAGC-3⬘), containing nucleotides 897 to 870 of the HTNV S segment ORF (underlined); and
C⌬255-3⬘ (5⬘-GTACTGCTCGAGTGGTTTCCGGATACCGTTAACATC-3⬘),
containing nucleotides 522 to 598 of the HTNV S segment ORF (underlined).
Construction of HTNV N proteins with N- and C-terminal deletions. Vent
polymerase (New England Biolabs) was used to PCR amplify each fragment.
PCR products were digested with NdeI and XhoI and ligated with T4 DNA ligase
directly into pET21b, which was also restriction digested with NdeI and XhoI.
The nucleotide sequences of the clones were confirmed by bidirectional sequencing of the constructs and analysis with a LiCOR 4200 IR2 automated sequencer.
In the following expression vector constructions, the numbers following NP refer
to the HTNV N protein amino acid sequence. The 5⬘ primer used for NP137–214
was 5⬘-GGGACGTCATATGGCTCTGTATATGTTGACAACAAGGGG-3⬘,
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which contained nucleotides 409 to 435 of the HTNV S segment ORF (underlined) and an NdeI site at the 5⬘ end. The 3⬘ primer for NP137–214 was 5⬘-GT
ACTGCTCGAGCTGCCGTGCCTTAATCTGTGCAGG ⫺3⬘, which contained
nucleotides 642 to 618 of the HTNV S segment ORF (underlined) and an XhoI
site at the 5⬘ end. The 5⬘ primer used for NP208–262 was 5⬘-CGACGTTCATA
TGGCACAGATTAAGGCACGGCAGATG-3⬘ and contained nucleotides 624
to 648 of the HTNV S segment ORF (underlined) and an NdeI site at the 5⬘ end.
The 3⬘ primer for NP208–262 was 5⬘-GTACTGCTCGAGGTTTGTTGCAGG
ACCACCAAGGAG-3⬘ and contained nucleotides 786 to 762 of the HTNV S
segment ORF (underlined) and an XhoI site at the 5⬘ end. The forward primer
for NP constructs NP175–217, NP175–232, NP175–249, NP175–270, and NP175–
300 was 5⬘-GTACTGGCTAGCAAACATCTTTACGTGTCCTTG-3⬘ and contained nucleotides 524 to 543 of the HTNV S segment ORF (underlined). The
forward primer has an NheI site in the 5⬘ end that cloned the gene adjacent to
a start codon in pET21B. The reverse primers for each of these constructs
contained an XhoI site at the 5⬘ end and were as follows: NP175–300 (5⬘-GTA
CTGCTCGAGCTCAATATCTTCAATCATGC-3⬘), NP175–270 (5⬘-GTACTG
CTCGAGTTGCCGCTGCCGTAAG-3⬘) NP175–249 (5⬘-GTACTGCTCGAGA
TCTGGAAGAAGCTTGC), NP175–232 (5⬘-GTACTGCTCGAGCCAGTCCT
TTGCTAATG-3⬘) and NP175–217 (5⬘-GTACTGCTCGAGACTGATCATCTG
CCGTG-3⬘). The sequence representing the HTNV S segment ORF is
underlined.
Expression and purification of truncated wild-type protein and deletions of
the HTNV N protein. N⌬209/pET23b, N⌬300/pET23b, NP137–214/pET21b,
NP208–262/pET21b, C⌬319/pRSET, NP213–316/pRSET, NP175–217/pET21b,
NP175–232/pET21b, NP175–249/pET21b, NP175–270/pET21b, and NP175–300/
pET21b were transformed into BL21(DE3) cells, and N⌬90/pET 21b, C⌬130/
pET 21b, and C⌬255/pET 21b were transformed into HMS174(DE3) cells.
C⌬319/pRSET and NP213–316/pRSET were gifts from Alexander Dekonenko,
U.S. Army Medical Research Institute for Infectious Diseases (USAMRIID), Ft.
Detrick, Frederick, Md. The wild-type HTNV N protein/pET21b was expressed
in HMS174(DE3). The N protein and its derivatives were expressed with the T7
polymerase expression system and purified as hexahistidine-tagged fusion proteins from the insoluble fraction as described previously (23). The final preparation was dialyzed against 0.5 M NaCl, 20 mM HEPES (pH 7.4), 1 mM EDTA,
1 mM dithiothreitol (DTT), and 20% (vol/vol) glycerol. Protein concentrations
were measured by the Bradford method (5) by the Bio-Rad Micro-Assay.
In vitro transcription and labeling of RNA substrates. pGEM1/HTNVS,
which contains the HTNV S segment cDNA cloned into the PstI site, was used
for in vitro transcription of genomic vRNA as described previously (24).
pGEM7Zf was used for in vitro transcription of a nonviral 67-nucleotide RNA
used as a control RNA. Briefly, the plasmids were purified with the QIAquick
miniprep kit (Qiagen) according to the manufacturer’s protocol. pGEM1/
HTNVS was digested with XbaI, and pGEM7Zf was digested with SmaI. Radiolabeled HTNV S segment RNA transcripts were produced from the linear
DNAs with a MaxiScript Sp6 RNA transcription kit (Ambion, Austin, Tex.). The
RNeasy kit (Qiagen) was used to purify transcripts. Purified RNA was stored at
⫺80°C for up to 2 weeks.
Filter binding assay. Purified HTNV N proteins and N protein deletions were
serially diluted (22.7, 7.57, 2.52, 0.84, and 0.28 M) in a final volume of 20 l of
binding buffer (40 mM HEPES [pH 7.4], 100 mM NaCl, 5% glycerol). The
samples were incubated at 37°C for 5 min, 1 ng of [␣-32P]UTP-labeled RNA was
then added to each reaction mixture, and the reaction mixtures were incubated
for an additional 15 min at 37°C. Binding reactions were slot blotted (Bio-Rad)
onto nitrocellulose filters as previously described (23). Signals were quantitated
with a Molecular Dynamics PhosphorImager and analyzed by ImageQuaNT
version 4.2 software (Molecular Dynamics).
GEMSA. For the gel electrophoresis mobility shift assay (GEMSA), 1 ng of
32
P-radiolabeled vRNA S segment, prepared as described above, was incubated
with 22.7 M purified N protein or N protein deletion in binding buffer (20 mM
HEPES [pH 7.4], 100 mM NaCl, 1 mM MgCl2, 0.2 mM DTT, 5% glycerol, 20 U
of RNase inhibitor [Ambion]) in a final reaction volume of 20 l and incubated
at 37°C for 20 min. Two microliters of sample buffer (80% glycerol and 0.2%
bromphenol blue) was added to each reaction mixture, the reaction mixtures
were loaded onto 1% agarose gel, separated by electrophoresis in 0.5⫻ Trisborate-EDTA (TBE) buffer at 120 V (constant voltage) for 1.5 h, and visualized
by autoradiography.
Competition experiments. Competition experiments were analyzed with the
filter binding assay. A constant concentration of the HTNV N peptides (3.5 ⫻
10⫺7 M) was incubated with 1 ng of [␥-32P]ATP-labeled RNA (0.05 nM) for 10
min at 37°C. RNAs were synthesized and polyacrylamide gel electrophoresis
(PAGE) purified by Integrated DNA Technologies. The RNAs used were
HTNV 5⬘-end vRNA(1–39) (5⬘-UAGUAGUAUGCUCCCUAAAAAGACAA
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FIG. 1. Schematic diagram of the blocks predicted for the hantavirus N protein and the locations of deletions constructed from the HTNV N
protein. Bioinformatic analysis of hantaviral N amino acid sequences by the BLOCKS database revealed nine distinct conserved regions (blocks),
which are designated PF00846A to -I. The alignment of nucleocapsid sequences used to generate the BLOCKS map are based on the following
virus sequences (with accession numbers given in parentheses): Hantaan (Swiss Prot P05133), Seoul (Swiss Prot ID P17881), Prospect Hill (Swiss
Prot ID P22047), and Puumala (Swiss Prot ID P41268) viruses. N⌬90 contained aa 91 to 429, N⌬209 contained aa 210 to 429, N⌬300 contained
aa 301 to 429, C⌬130 contained aa 1 to 299, C⌬255 contained aa 1 to 174, and C⌬319 contained aa 1 to 110. The remaining N protein deletion
constructs were named based on the amino acids of the HTNV N protein that were contained in the clone. For example, NP175–217 contains aa
175 through 217.

UCAAGGAGCAAUC-3⬘) HTNV 3⬘-end vRNA(1661–1696) (5⬘-CGUUGUUC
UAGUAGCUCUUUAGGGAGUCUACUACUA-3⬘), and random RNA (5⬘-A
CCAACAAAGAUGAGUGUUACAGCUCUUGC-3⬘). Various concentrations (0.05 to 500 nM) of unlabeled RNA were added to the binding reaction
mixtures, and a further 10-min incubation followed. The reaction mixtures were
slot blotted onto nitrocellulose filters as described previously (24). Analyses of
the competition assays from the filter binding experiments were performed by a
nonlinear fit of the data by using the Origin program (MicroCal).

RESULTS
Design and construction of HTNV N protein deletions. The
BLOCKS database was used to identify highly conserved regions in the hantavirus N protein family (10). This database
prepares multiply aligned, ungapped amino acid sequences for
a protein family. By using the amino acid sequences of several
hantavirus N proteins, the Block Maker program revealed nine
distinct, conserved regions, or blocks, which were designated A
to I (Fig. 1). To map the RNA binding region of HTNV N
protein, 14 truncated constructs were prepared to remove the
conserved blocks in the N-terminal, C-terminal, or both regions of the N protein. HTNV N protein derivatives included
N⌬90, N⌬209, and N⌬300, which had N-terminal deletions of
90, 209, and 300 amino acids (aa), respectively (Fig. 1). N⌬90
lies just inside block B, and represents one of several deletions
constructs (data not shown) made in this region. C-terminally
deleted HTNV N proteins included C⌬130, C⌬255, and
C⌬319, which removed 130, 255, and 319 aa from the C terminus. NP137–214, NP208–262, NP213–316, NP175–217,

NP175–232, NP175–249, NP175–270, and NP175–300 had
both N-terminal and C-terminal deletions. The nomenclature
of the proteins with N- and C-terminal deletions provides the
HTNV N protein amino acids expressed in the numbers that
follow NP.
Expression and purification of truncated HTNV N protein
deletions. Several different host strains, HMS174(DE3), Novablue(DE3), BL21(DE3), BLR, and BL21(DE3)pLysS, were
examined to see if the level of HTNV N protein expression
could be improved. None of the hosts tested showed a substantial increase in expression levels when compared to the
other strains, except for HMS174(DE3), which showed a
slightly higher level for the wild-type N protein (data not
shown). Therefore, we chose to express HTNV N protein and
deletion constructs in either BL21(DE3) cells or
HMS174(DE3) cells. In these two hosts, all constructs showed
similar levels of expression, except N⌬90, which expressed
poorly, and NP208–262, which had a slightly lower level of
expression (data not shown). Additional deletions were created—N⌬105, for example—but none of these showed a stably
expressed protein product (data not shown). Thus, creation of
stable expression constructs with deletions in the N terminus
from aa 90 to 105 proved to be difficult.
Each of the truncated HTNV N proteins was purified by
Ni2⫹-NTA chromatography and examined for its level of purity by sodium dodecyl sulfate (SDS)-PAGE or Tricine SDSPAGE (Fig. 2). The column fraction eluates from the N pro-
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tein truncations—C⌬255 (Fig. 2A, lane 1), C⌬130 (Fig. 2A,
lane 2), N⌬300 (Fig. 2A, lane 3), and N⌬209 (Fig. 2A, lane 4)
NP213–316 (Fig. 2B, lane 4), and C⌬319 (Fig. 2B, lane 5)—
showed a high level of purity (greater than 95%). Protein
products—NP208–262 (Fig. 2B, lane 2) and NP137–214 (Fig.
2B, lane 3)—were slightly less homogenous in the preparations
shown. The expression product N⌬90 (Fig. 2A, lane 5) was
difficult to purify, and its low yield and purity made it unsuitable for subsequent functional studies. The HTNV N proteins
with truncation in the N and C terminus—NP175–217, NP175–
300, NP175–270, NP175–249, and NP175–232 (Fig. 2C, lanes
1–5)—were easily purified to greater than 95% homogeneity.
Western blot analysis of the purified proteins showed them to
be stable throughout the purification procedures as noted by
an absence of proteolysis (data not shown).
Filter binding analysis of the binding affinity of the HTNV N
protein and deletion derivatives to HTNV S segment RNA. The
binding affinity of purified wild-type N protein and deletions of
the N protein to in vitro-transcribed radiolabeled HTNV S
segment vRNA was measured by filter binding. The percentage
of vRNA bound was measured for several concentrations of
each protein. At the highest concentrations of protein assayed,
both wild-type and C⌬130 bound 100% of the input RNA (Fig.
3). N⌬209, NP208–262, and NP137–214 bound ⬃50, 64, and
73% of the vRNA, respectively. C⌬255 and NP213–316 bound
less than 5% of the vRNA, and N⌬300 and C⌬319 did not bind
the vRNA. These data demonstrated that the entire RBD was
contained in C⌬130 (aa 1 to 299), while C⌬255 (aa 1 to 174),
which had less than 5% binding activity, probably contained
few amino acids, if any of the RBD. Therefore, the RBD was
inferred to be within aa 174 to 299. Five additional deletions of
the HTNV N protein were made in order to resolve the boundaries of the RBD within aa 174 to 299. Purified protein expression products from each of the five constructs, NP175–300,
NP175–270, NP175–249, NP175–232, and NP175–217, were
examined for their binding affinity for S-segment vRNA in a
filter binding assay (Table 1). At the highest concentration, all
of the deletion products showed approximately 70% or greater
binding compared to the wild-type N protein. NP175–249 and
NP175–232, showed the greatest amount of binding (85 and
79%, respectively). We consistently observed higher filter binding of protein derivatives that contained only aa 217 to 249
than those that were larger (aa 175 to 300) and smaller (aa 175
to 217). The reason for the decrease in binding with constructs
that contain aa 217 to 249 were unclear. It is possible that these

FIG. 2. SDS-PAGE analysis of the full-length (wild-type [WT])
HTNV N protein and truncated HTNV N protein purified by nickel
affinity chromatography. (A) Purified proteins shown are shown as
follows: lane 1, C⌬255; lane 2, C⌬130; lane 3, N⌬300; lane 4, N⌬209;
lane 5, N⌬90; and lane 6, wild-type N protein. (B) Purified proteins are
shown as follows: lane 2, NP208–262; lane 3, NP137–214; lane 4,
NP213–316; and lane 5, C⌬319. Molecular mass markers (M) are
shown in lanes 1 and 7 in panels A and B, respectively. (C) Purified
proteins are shown as follows: lane 1, NP175–217; lane 2, NP175–300;
lane 3, NP175–270; lane 4, NP175–249; and lane 5, NP175–232. In
panels A and B, the symbols C⌬ and N⌬ along with the number refer
to the amino acids truncated in the N or C terminus, respectively. In
panels B and C, the protein designation refers to the region of the
HTNV N protein amino acid expressed by the construct.
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FIG. 3. Filter binding analysis of the full-length HTNV N protein and truncated N proteins. N proteins were incubated with the S segment
vRNA and examined for their binding affinity with a filter-binding assay as described in Materials and Methods. Shown are the mean and standard
error of a minimum of two assays done in duplicate with the fraction of substrate retained on the membrane. An additional control was included
in the analysis: the wild-type N protein with a nonviral 67-nucleotide RNA transcribed from pGEM7Zf, shown as the wild-type control (WT-ctr).
The x axis shows the N protein concentration, and the y axis shows the amount of vRNA bound (percent).

fragments contain domains that have additional functions such
as protein-protein interactions that compete with the RNA
binding function (2). Together, the filter binding data defined
a minimal RBD between amino acid residues 175 and 217 that
may extend into aa 217 to 249.
GEMSA analysis of complexes formed with the HTNV N
protein and deletion derivatives with HTNV S segment RNA.
The interaction between wild-type or the truncated HTNV N
proteins with the vRNA was also investigated with a GEMSA.
HTNV N protein and each of the deleted proteins were incubated with the in vitro-transcribed radiolabeled vRNA S segment, and the complexes were resolved by separation on agarose gels (Fig. 4). Substantial levels of protein-RNA complexes
were observed with reactions containing HTNV N protein wild
type (Fig. 4A, lane 2), C⌬130 (Fig. 4A, lane 5), NP208–263
(Fig. 4A, lane 9), and NP137–214 (Fig. 4A, lane 10). A small
amount of protein-vRNA complex was observed in the reacTABLE 1. Percentage of S segment vRNA bound to HTNV
N protein and HTNV N protein derivatives as measured
by filter binding
% of vRNA bound to N protein derivative:

N
protein
(M)

Wild
type

NP175–
217

NP175–
232

NP175–
249

NP175–
270

NP175–
300

22
7.6
2.5
0.8
0.3

100
47
5
1
0.6

70
7.8
3
1
0.7

79
20
4
2
0.9

85
19
5
1
0.4

73
15
2
0.5
0.5

67
15
3
0.8
0.7

tion mixtures containing the N protein derivatives N⌬209 (Fig.
4A, lane 3) and NP213–316 (Fig. 4A, lane 8). To further map
the RBD within the region 175 to 300, five additional HTNV N
protein deletions were made, purified, and analyzed by
GEMSA. The following constructs provided a deletion analysis
of the C-terminal boundary of the RBD (in order of decreasing
size): NP175–300, NP175–270, NP175–249, NP175–232, and
NP175–217. Each of the deletion products showed a similar
level of binding in the GEMSA (Fig. 4B). The levels of complex formation were similar to those observed in the filter
binding assay (Fig. 4 and Table 1). Two of the proteins analyzed in these studies, NP137–214 and NP175–232, consistently
showed an additional higher order of complex formation in the
GEMSA. NP175–232 also showed the highest amount of binding by filter binding analysis. These results suggest that this
region of the protein when expressed without adjacent regions
has the ability to form higher-order protein complexes or aggregates. At this time, it is unclear as to whether or how this is
biologically relevant to what is known regarding hantavirus N
protein oligomerization (2).
Competition analysis of the minimal RBD of HTNV N protein. To corroborate the location of the functional RBD of the
HTNV N protein, two synthetic peptides, N1 and N2, were
made based on the HTNV N protein amino acid sequence 175
to 218 (N1, KHLYVSLPNAQSSMKAEEIT; and N2,
PGRYRTAVCGLYPAQIKARQMIS). We were unable to
produce the entire region as one peptide due to a breakdown
somewhere near the two consecutive serines (Sigma-Genosys,
personal communication). We investigated the ability of unlabeled oligoribonucleotides to compete with complexes made

3306

J. VIROL.

XU ET AL.

with 32P-labeled HTNV S segment oligoribonucleotides and
each peptide. A constant concentration of two N protein oligopeptides with amino acid sequences corresponding to Lys175 through Thr-195 (N1) and Pro-196 through Ser-218 (N2)
was incubated with [␥-32P]ATP-labeled HTNV vRNA(1–39)
(0.05 nM) and increasing concentrations (0.05 to 500 nM) of
unlabeled competitor RNA (Fig. 5A). The level of each complex was measured by filter binding. The vRNA(1–39) representing the 5⬘ end of the HTNV S segment vRNA showed the
greatest ability to compete compared to the 3⬘-end
vRNA(1661–1696) or random RNA (Fig. 5A). Competition of
complexes of the combined peptides (N1 and N2) with 32Plabeled 5⬘-end vRNA(1–39) by the unlabeled 5⬘-end vRNA(1–
39) was approximately 55% at 500 nM.
The two peptides were also analyzed individually in the
competition assay. N2 had good binding activity (Fig. 5B),
while N1 showed no RNA binding activity (data not shown). In
the competition analysis of the N2-vRNA complex, the 5⬘-end
vRNA(1–39) at a concentration of 500 nM reduced binding by
approximately 68% (Fig. 5B). The 3⬘-end vRNA(1661–1696)
and the random RNAs were not effective competitors of the
N2-vRNA complex; although at the highest levels of competitor RNA, we observed a 30% reduction in the binding. When
compared to the competition data with both peptides, these
data suggest that N2 provides the major determinant of the
binding affinity of the RBD. However, N2 alone has reduced
specificity compared to N1 and N2 combined. The specificity of
this activity was enhanced substantially by the addition of N1.
The neurogranin peptide (AAKIQASFRGHMARKK) was
used as a control in these filter-binding assays. Neurogranin
peptide has a similar molecular weight and is composed of a
similar number of hydrophobic amino acids as compared to
peptides N1 and N2. Neurogranin peptide did not bind to any
of the oligoribonucleotides (data not shown). In summary,
these data suggest that the region of the N protein corresponding to amino acids Pro-196 through Ser-218 (N2) as well as
determinants in peptide N1(175–195) are required for a functional RBD.
DISCUSSION

FIG. 4. GEMSA of HTNV N protein, the wild type (WT), and
deletions. (A) Binding affinities were examined by GEMSA with in
vitro-transcribed full-length HTNV S segment vRNA and the expressed wild-type N protein (lane 2), N⌬209 (lane 3), N⌬300 (lane 4),
C⌬130 (lane 5), C⌬255 (lane 6), NP⌬319 (lane 7), NP213–316 (lane 8),
NP137–214 (lane 9), and NP208–262 (lane 10). A no-protein control is
presented in lane 1. (B) Binding affinities were examined by GEMSA
with in vitro-transcribed full-length HTNV S segment vRNA and the
expressed wild-type N protein (lane 2), NP175–217 (lane 3), NP175–
232 (lane 4), NP175–249 (lane 5), NP175–270 (lane 6), NP175–300
(lane 7), C⌬130 (lane 8), and C⌬255 (lane 9). A no-protein control is
presented in lane 1. In panels A and B, a 22.7 M concentration of
wild-type N protein and each deletion mutant was incubated with
radiolabeled vRNA S segment. The reaction mixtures were loaded
onto a 1% agarose gel after an incubation period of 20 min, and the
protein-RNA complexes were separated from free RNA by gel electrophoresis as described in Materials and Methods.

The hantavirus N protein plays an important role in the
formation of the RNP complex of each genomic segment of
vRNA and assembly of the RNPs into the virion. The N protein may also play a vital role in viral replication and transcription. During these various activities, the N protein must interact differentially with the vRNAs. There has been only one
report that has addressed the location of the hantavirus RBD
in the N protein. In that study, a nonspecific RBD was localized to the carboxyl-terminal amino acids of the HTNV and
Puumala virus N proteins (9). Motifs common to other RNA
binding proteins (25) have not been identified in hantaviral N
proteins.
To identify the RBD of the HTNV N protein that specifically interacts with the vRNAs, we prepared and examined
expression products from a series of several N- and C-terminal
deletion constructs. Filter and GEMSA binding studies
showed a minimal RBD from aa 175 to 217 (Fig. 6 and Table
2). Additional binding determinants may also extend to aa 232.
We hypothesize that the RBD does not extend past aa 232. In
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FIG. 6. Alignment of the minimal RBD of the HTNV N protein
with the same region in other hantavirus N proteins. Top, Topogravof
virus; PUU, Puumala virus; ISLA, Isla Vista virus; PH, Prospect Hill
virus; SN, Sin Nombre virus CC107; and HTN, Hantaan virus.

nucleocapsid proteins bind vRNA through a localized, conserved domain. For example, a conserved region in the C
terminus of the rabies virus N protein, aa 298 to 352, binds
directly to the vRNA (14). In the influenza virus nucleoprotein,
a highly conserved region among A-, B- and C- type viruses was
mapped (1, 13). Similarly, a central, conserved region of the
mouse hepatitis virus N protein, aa 169 to 308, comprises the
RBD (15, 16). As with the region we mapped in the HTNV N
protein, none of the canonical consensus RNA binding motifs
has been identified in these proteins. Furthermore, at present,
no apparent similarity has been noted among these RBDs.
Identification of common features of RBDs among the hantaviral nucleocapsid proteins may require elucidation of their
three-dimensional structures.
To confirm the contribution of amino acids or the effect of
the absence of amino acids in binding the RNA, we investigated the ability of unlabeled synthetic oligoribonucleotides to
compete with 32P-labeled HTNV 5⬘-end vRNA in a filterbinding assay. Neither 3⬘-end vRNA nor random RNA was an
effective competitor of the N1/N2-vRNA or N2-vRNA complexes. These data suggest that the N2 provides major determinants of the binding affinity noted by the RBD, but the
specificity of this activity was enhanced substantially by the
presence of N1. In a previous study by Gott et al., the Cterminal region of the HTNV and PUUV N proteins were
shown to have a nonspecific RNA binding ability (9). The
central region (aa 120 through 334) of the HTNV protein was
not examined. It is difficult to compare our results with these,
TABLE 2. Summary of RNA binding levels for HTNV N protein
and derivatives with the S segment vRNA
FIG. 5. Competition experiments. (A) Two N protein oligopeptides (N1 and N2) were bound to 1 ng of [␥-32P]ATP-labeled 5⬘-end
vRNA(1–39) in the presence of variable concentrations (0.5 to 500
nM) of 5⬘-end vRNA(1–39), 3⬘-end vRNA(1661–1696), and a random
RNA. (B) Competition experiments with N2 oligopeptide and the
three synthetic oligoribonucleotides. Analyses of competition assays
were performed by fitting a binding curve to the empirical filter binding
data by using the Origin program (Microcal).

addition to the evidence provided by deletion mapping, the
amino acids that follow 232 are highly nonconserved (aa 233 to
309). It is generally held that nonconserved regions are less
likely to contain functional domains. Exploration of the region
identified showed it to have a 58% identity and an 86% similarity among the six hantavirus N protein sequences (Fig. 6).
Studies with other RNA viruses have also reported that the

Protein

Wild type
N⌬209
N⌬300
C⌬130
C⌬255
C⌬319
NP213–316
NP137–214
NP208–262
NP175–300
NP175–270
NP175–249
NP175–232
NP175–217
a

Deletiona

None
N
N
C
C
C
N and
N and
N and
N and
N and
N and
N and
N and

C
C
C
C
C
C
C
C

aa

Filter binding
(%)

Gel shift
resultb

1–429
210–429
301–429
1–299
1–174
1–119
213–316
137–214
208–262
175–300
175–270
175–249
175–232
175–217

100
50
⬍5
100
⬍5
⬍5
⬍5
73
64
67
73
85
79
70

⫹⫹⫹⫹
⫹⫹
⫺
⫹⫹⫹⫹
⫺
⫺
⫹
⫹⫹⫹
⫹⫹
⫹⫹⫹⫹
⫹⫹⫹⫹
⫹⫹⫹⫹
⫹⫹⫹⫹
⫹⫹⫹⫹

Deletion created in the N and/or C terminus of the HTVN N protein.
Symbols refer to approximate level compared to (⫹⫹⫹⫹): the wild type
⫹⫹⫹, ⬃75 to 100%; ⫹⫹, ⬃50 to 75%; ⫹, ⬍25%; ⫺, no binding.
b
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because Gott et al. used a different method to measure the
RNA binding interaction. However, it is plausible that additional regions of the N protein contribute to the interaction
with the vRNAs. In other studies that have attempted to map
the RBDs of other viral nucleoproteins, different groups have
mapped distinct regions. For example, in addition to the influenza virus work discussed above (1, 13), a recent mutational
analysis of the influenza virus N protein found that several
amino acids scattered throughout the protein were crucial for
viral RNA binding (8). Studies of the HIV-1 nucleocapsid
protein have also mapped a distinct region involved in the
interaction with the virus genome (3) as well as the involvement of basic amino acids throughout the nucleocapsid protein
(6). In the case of HIV-1, it has been proposed that the nonspecific interactions of the basic residues drive the assembly of
the Gag polymerization and virion assembly though their interaction with RNA. The regions of the HTNV N protein
reported herein and the previous report may also reflect the
specific and nonspecific interactions of the protein with RNA.
Amino acids that are known to interact with nucleic acids
include Lys, Arg, Asp, Glu, Thr, Ser, and Tyr (7). Fifteen of the
43 aa of the HTNV N protein RBD (Fig. 6) contain these
residues: Lys and Arg comprise 11.6% of the amino acids,
while Asp and Glu comprise an additional 4.7%, and Thr, Ser,
and Tyr represent 18.6% of the amino acids in this region. The
full-length HTNV N protein has a similar level of the basic
residues, 11% Lys and Arg, but twice the amount of acidic
residues: 10.6% are Glu/Asp. The full-length protein also has
slightly fewer Thr, Tyr, and Ser residues: 15.9%. Future work
will define the importance of each of these three groups in
mediating the N protein’s interaction with vRNA and nonvRNA.
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